Correlation of PROMIS scales and clinical measures among chronic obstructive pulmonary disease patients with and without exacerbations
- 12 October 2014
- journal article
- research article
- Published by Springer Nature in Quality of Life Research
- Vol. 24 (4) , 999-1009
Abstract
The Patient-Reported Outcomes Measurement Information System (PROMIS®) initiative was developed to advance the methodology of PROs applicable to chronic diseases. Chronic obstructive pulmonary disease (COPD) is a progressive chronic disease associated with poor health. This study was designed to examine the correlation of PROMIS health-related quality of life (HRQOL) scales and clinical measures among COPD patients.Keywords
This publication has 36 references indexed in Scilit:
- Validity of two new patient‐reported outcome measures in systemic sclerosis: Patient‐reported outcomes measurement information system 29‐item health profile and functional assessment of chronic illness therapy–dyspnea short formArthritis Care & Research, 2011
- Standardizing Measurement of Chronic Obstructive Pulmonary Disease Exacerbations: Reliability and Validity of a Patient-reported DiaryAmerican Journal of Respiratory and Critical Care Medicine, 2011
- Comparison of health-related quality of life measures in chronic obstructive pulmonary diseaseHealth and Quality of Life Outcomes, 2011
- Development of the EXAcerbations of Chronic Obstructive Pulmonary Disease Tool (EXACT): A Patient-Reported Outcome (PRO) MeasureValue in Health, 2010
- Relative to the general US population, chronic diseases are associated with poorer health-related quality of life as measured by the Patient-Reported Outcomes Measurement Information System (PROMIS)Journal of Clinical Epidemiology, 2010
- Influência dos parâmetros funcionais respiratórios na qualidade de vida de pacientes com DPOCJornal Brasileiro de Pneumologia, 2009
- Co-morbidity in older patients with COPD—its impact on health service utilisation and quality of life, a community studyAge and Ageing, 2006
- Anxiety and Depression in COPD: A Call (and Need) for Further ResearchCOPD: Journal of Chronic Obstructive Pulmonary Disease, 2005
- Combined salmeterol and fluticasone in the treatment of chronic obstructive pulmonary disease: a randomised controlled trialThe Lancet, 2003
- Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary diseaseThorax, 1999